Synstim 50 mg Combipack Injection 1's is used in the treatment of Multiple myeloma, advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma. The detailed uses of Synstim 50 mg Combipack Injection 1's are as follows:&lt;br/&gt;&bull; Treat multiple myeloma: Synstim 50 mg Combipack Injection 1's is commonly used as a palliative treatment to relieve symptoms of multiple myeloma, a cancer of plasma cells in the bone marrow. It may also be used as high-dose conditioning before stem cell transplantation.&lt;br/&gt;&bull; Manage ovarian cancer: Synstim 50 mg Combipack Injection 1's is used for patients with advanced ovarian carcinoma, helping to slow the growth and spread of cancer cells.&lt;br/&gt;&bull; Support treatment of uveal melanoma with liver metastases: Synstim 50 mg Combipack Injection 1's can be used in specialized settings to treat uveal melanoma that has spread to the liver, often via intra-arterial administration.&lt;br/&gt;&bull; Prepare for bone marrow transplant: Synstim 50 mg Combipack Injection 1's is used to destroy bone marrow and cancer cells prior to hematopoietic stem cell transplantation, especially in patients with multiple myeloma.&lt;br/&gt;

Medicinal Benefits:

Synstim 50 mg Combipack Injection 1's is an alkylating medicine, also known as a chemotherapeutic agent, primarily used to treat various cancer conditions such as multiple myeloma (a type of cancer that develops from cells in the bone marrow called plasma cells), advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma. Melphalan, present in Synstim 50 mg Combipack Injection 1's, works by reducing the number of abnormal cells produced by your body. As a result, it effectively treats cancer.

FAQs

What is the use of Synstim 50 mg Combipack Injection 1's?

Synstim 50 mg Combipack Injection 1's is used to treat Multiple myeloma, advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma.

How does Synstim 50 mg Combipack Injection 1's work?

Synstim 50 mg Combipack Injection 1's contains Melphalan, which works by reducing the number of abnormal cells your body makes. Thus, it treats cancer efficiently.

What important things should I take care of while taking Synstim 50 mg Combipack Injection 1's?

While taking Synstim 50 mg Combipack Injection 1's, make sure to attend all of your doctor's appointments to ensure the therapy is effective. Blood tests and weight checks must be monitored on a regular basis. Both men and women should utilize an effective method of contraception while taking Synstim 50 mg Combipack Injection 1's.

Synstim 50 mg Combipack Injection 1's causes a drop in blood cell count?

Melphalan can cause a significant decrease in the number of blood cells and platelets. Your doctor may suggest laboratory tests before and during the treatment.